Drawing for KAIRA

USPTO serial 79351233

KAIRA

Reviewed by CopyMark Law Group

Reg. 7393879Status 700Registered
Filing date
Status date
Registration date
May 28, 2024
Examiner
SEVERSON, JUSTIN
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with KAIRA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

William E. Anderson

William E. Anderson Christensen Fonder Dardi & Herbert PLLC11322 86th Avenue NorthMaple Grove, MN 55369UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Reagents for measurement of HBs antibody; glue coated strips for use against vermin; medicine cases, portable, filled, namely, medical diagnostic kits consisting primarily of clinical medical reagents being oligonucleotides, enzymes, and nucleotides, and also containing DNA primers and biochemical probes, fluorescent reference dye, and reaction buffers for nucleic acid genotyping, nucleic acid quantification and nucleic acid amplification, and polymerase chain reaction and reverse transcription polymerase chain reaction for use in clinical laboratories, hospitals, point-of-care and direct consumer applications; medical diagnostic reagents for immunization disease; mothproofing paper; bacterial preparations for veterinary purposes; reagent paper for veterinary purposes; reagents for use in veterinary genetic testing; milk sugar for pharmaceutical purposes; medicated plasters; cultures of microorganisms for medical use in dietary supplements and food supplements; reagent paper for medical purposes; reagents for use in medical genetic testing; preparations for detecting mutation in prion genes for medical purposes; chemical reagents for medical purposes; medical diagnostic reagents; chemical preparations for the diagnosis of pregnancy; diagnostic biomarker reagents for medical purposes; lining materials for dental purposes; Diagnostic preparations for medical purposes in the nature of preparations for diagnosing tuberculosisACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 30, 2024FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 10, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 10, 2024FIMPFINAL DISPOSITION PROCESSED—
Aug 28, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 28, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
May 28, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 25, 2024OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Mar 12, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 12, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 11, 2024GPNXNOTIFICATION PROCESSED BY IB—
Mar 6, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 6, 2024OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Feb 21, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 21, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 21, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 21, 2024OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 5, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 9, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 9, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 9, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 15, 2023RFNTREFUSAL PROCESSED BY IB—
Jul 21, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 21, 2023RFRRREFUSAL PROCESSED BY MPU—
Jun 16, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 15, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 1, 2023DOCKASSIGNED TO EXAMINER—
Oct 4, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 30, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 29, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance